MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, KLRS has $81,175K in assets. $39,310K in debts. $42,387K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1289.08%
Cash Ratio
698.88%
Debt to Asset Ratio
48.43%
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty obligation - related par...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
42,387 88,426
Short-term investments
34,612 -
Prepaid expenses and other current assets
1,184 3,225
Total current assets
78,183 91,651
Deferred transaction costs
0 0
Operating lease right-of-use assets
1,516 -
Restricted cash
500 500
Other non-current assets
976 691
Total assets
81,175 92,842
Accounts payable
494 3,680
Convertible promissory notes, net of discount of 1,298 (including 0 and 18,670 due to a related party)
0 0
Derivative liabilities (including 0 and 995 due to a related party)
0 0
Tranche liability (including 0 and 331 due to a related party)
0 0
Accrued expenses and other current liabilities (including 64 and 85 due to a related party)
5,195 3,971
Operating lease liabilities, current
376 -
Total current liabilities
6,065 7,651
Royalty obligation - related party
32,076 32,076
Operating lease liabilities, long-term
1,169 -
Total liabilities
39,310 39,727
Common stock, 0.0001 and 0.00001 par value as of september 30, 2025 and december 31, 2024, respectively 300,000,000 and 86,000,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively 18,702,418 and 1,356,431 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
2 2
Additional paid-in capital
191,858 191,220
Accumulated other comprehensive income
6 -
Accumulated deficit
-150,001 -138,107
Total stockholders' equity (deficit)
41,865 53,115
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)
81,175 92,842
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$1,184K Short-term investments$34,612K Cash and cashequivalents$42,387K Other non-currentassets$976K Restricted cash$500K Operating leaseright-of-use assets$1,516K Total current assets$78,183K Total assets$81,175K Total liabilities,redeemable convertible...$81,175K Total stockholders'equity (deficit)$41,865K Total liabilities$39,310K Accumulated deficit-$150,001K Accumulated othercomprehensive income$6K Additional paid-in capital$191,858K Operating leaseliabilities, long-term$1,169K Royalty obligation -related party$32,076K Total currentliabilities$6,065K Common stock, 0.0001and 0.00001 par...$2K Operating leaseliabilities, current$376K Accrued expenses andother current...$5,195K Accounts payable$494K

Kalaris Therapeutics, Inc. (KLRS)

Kalaris Therapeutics, Inc. (KLRS)